Bharat Biotech refused to supply Covaxin to Delhi on Centre's orders: Sisodia

Delhi / Bharat Biotech refused to supply Covaxin to Delhi on Centre's orders: Sisodia
Delhi - Bharat Biotech refused to supply Covaxin to Delhi on Centre's orders: Sisodia
New Delhi: Deputy chief minister of Delhi Manish Sisodia on Wednesday tweeted a letter written by Bharat Biotech in response to his demand that additional vaccines for coronavirus disease (Covid-19) be provided to the national capital, and said that the pharmaceutical company refused to comply citing directives of the central government and limited supply. 

"We are forced to shut down 100 Covaxin vaccination sites in 17 schools due to no supply," the minister said, adding that exporting 6.6 crore doses was the "biggest mistake". Till March, India had supplied more than 6.6 million doses of Covid-19 vaccines, mostly Covishield, to 76 countries.

Bharat Biotech's letter said the unprecedented demand for Covaxin was difficult to meet even as the firm had increased production. "...in spite of increasing production every month, we are unable to keep up with the demand. Further, we are making dispatches as per the directions of the government officials concerned. We therefore sincerely regret that we cannot make any additional supplies as required by you," the letter read.

Pune-based Serum Institute of India (SII) and Bengaluru's Bharat Biotech are the only two manufacturers of Covid-19 vaccine in India.

In March-end, as it was becoming difficult for the two firms to meet the vaccine demand even within India, it was decided that the focus will be shifted on domestic vaccination programme instead of exports, officials familiar with the development had told Hindustan Times.

The Delhi government, meanwhile, has been complaining of vaccine shortage for the past week. A day after saying the city's Covaxin stock was about to get over in one day Covishield's in another four days, the Delhi government said it had to shut down 125 vaccination centres catering to citizens in the 18-44 age group on Tuesday.

Disclaimer

अपनी वेबसाइट पर हम डाटा संग्रह टूल्स, जैसे की कुकीज के माध्यम से आपकी जानकारी एकत्र करते हैं ताकि आपको बेहतर अनुभव प्रदान कर सकें, वेबसाइट के ट्रैफिक का विश्लेषण कर सकें, कॉन्टेंट व्यक्तिगत तरीके से पेश कर सकें और हमारे पार्टनर्स, जैसे की Google, और सोशल मीडिया साइट्स, जैसे की Facebook, के साथ लक्षित विज्ञापन पेश करने के लिए उपयोग कर सकें। साथ ही, अगर आप साइन-अप करते हैं, तो हम आपका ईमेल पता, फोन नंबर और अन्य विवरण पूरी तरह सुरक्षित तरीके से स्टोर करते हैं। आप कुकीज नीति पृष्ठ से अपनी कुकीज हटा सकते है और रजिस्टर्ड यूजर अपने प्रोफाइल पेज से अपना व्यक्तिगत डाटा हटा या एक्सपोर्ट कर सकते हैं। हमारी Cookies Policy, Privacy Policy और Terms & Conditions के बारे में पढ़ें और अपनी सहमति देने के लिए Agree पर क्लिक करें।